Accendra Health Overview

  • Year Founded
  • 1881

Year Founded

  • Status
  • Public

  • Employees
  • 6,500

Employees

  • Stock Symbol
  • ACH

Stock Symbol

  • Investments
  • 14

  • Share Price
  • $0.15
  • (As of Thursday Closing)

Accendra Health General Information

Description

Accendra Health Inc is a nationwide provider of products, technology, and services that support health beyond the hospital by connecting patients, providers, and insurers. Through its brands, Apria and Byram Healthcare, the company delivers disposable medical supplies, integrated home healthcare equipment, and related services that help improve health outcomes and quality of life for individuals with chronic, complex, and acute health conditions. Its offerings span diabetes treatment, home respiratory therapy, and obstructive sleep apnea treatment, along with patient support services. The company also supplies a broad range of home medical equipment and patient care products, including ostomy, wound care, urology, and incontinence solutions.

Contact Information

Formerly Known As
O&M Holding, Owens & Minor
Ownership Status
Publicly Held
Financing Status
Formerly PE-Backed
Corporate Office
  • 10900 Nuckols Road
  • Suite 400
  • Glen Allen, VA 23060
  • United States
+1 (804)
Primary Industry
Logistics
Other Industries
Hospitals/Inpatient Services
Medical Supplies
Stock Exchange
NYS
Corporate Office
  • 10900 Nuckols Road
  • Suite 400
  • Glen Allen, VA 23060
  • United States
+1 (804)

Accendra Health Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Accendra Health Stock Performance

As of 12-Nov-2026, Accendra Health’s stock price is $0.15. Its current market cap is $11.2M with 77M shares.

(As of Thursday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$0.15 $0.15 $0.13 - $4.69 $11.2M 77M 2.48M -$2.23

Accendra Health Financials Summary

As of 30-Sep-2026, Accendra Health has a trailing 12-month revenue of $2.55B.

In Thousands,
USD
TTM 30-Sep-2026 FY 2025 31-Dec-2025 FY 2024 31-Dec-2024 FY 2023 31-Dec-2023
EV 1,816,921 2,380,346 3,135,377 3,597,794
Revenue 2,551,756 2,762,032 2,680,112 2,552,572
EBITDA 214,673 219,754 (41,038) 342,405
Net Income (171,563) (1,100,642) (362,686) (41,301)
Total Assets 2,078,914 2,451,761 4,656,156 5,093,322
Total Debt 1,815,497 2,120,193 1,930,725 2,319,931
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Accendra Health Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Accendra Health‘s full profile, request access.

Request a free trial

Accendra Health Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Accendra Health Inc is a nationwide provider of products, technology, and services that support health beyond the hospit
Logistics
Glen Allen, VA
6,500 As of 2025

Melsungen, Germany
 

Edmonton, Canada
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Accendra Health Competitors (13)

One of Accendra Health’s 13 competitors is B. Braun, a Corporation company based in Melsungen, Germany.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
B. Braun Corporation Melsungen, Germany
PRIMED Medical Products Corporation Edmonton, Canada
Avanos Medical Deutschland Corporation Hamburg, Germany
Mölnlycke Health Care Private Equity-Backed Mölndal, Sweden
O&m Halyard Apac Corporation Gosford, Australia
You’re viewing 5 of 13 competitors. Get the full list »

Accendra Health Patents

Accendra Health Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20260150922-A1 Reinforced fingertip disposable glove Pending 04-Dec-2024
WO-2026122655-A1 Reinforced fingertip disposable glove Pending 04-Dec-2024
US-20260117437-A1 Meltblown material formed from bicomponent polyester and polyolefin fibers Pending 31-Oct-2024
WO-2026093808-A1 Meltblown material formed from bicomponent polyester and polyolefin fibers Pending 31-Oct-2024
US-20260117436-A1 Meltblown material formed from bicomponent polyolefin and polyester fibers Pending 31-Oct-2024 D04H1/43828
To view Accendra Health’s complete patent history, request access »

Accendra Health Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Accendra Health Investments & Acquisitions (14)

Accendra Health’s most recent deal was a Later Stage VC with Lite Run for . The deal was made on 10-Jun-2026.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Lite Run 10-Jun-2026 Later Stage VC Therapeutic Devices
Lite Run 21-Feb-2025 Later Stage VC Therapeutic Devices
Apria 29-Mar-2022 Merger/Acquisition Clinics/Outpatient Services
American Contract Systems 16-Dec-2021 Merger/Acquisition Other Healthcare Services
Halyard Health (surgical and infection prevention business) 30-Apr-2018 Merger/Acquisition Other Healthcare Services
You’re viewing 5 of 14 investments and acquisitions. Get the full list »

Accendra Health ESG

Risk Overview

Risk Rating

Updated November, 04, 2026

10.45 | Low Risk

Risk Scale

A lower score indicates better sustainability

Negl

0-10

Low

10-20

Med

20-30

High

30-40

Severe

40+

Exposure

Exposure refers to the extent to which a company is exposed to different material ESG issues

Management

Management is related to actions taken to manage ESG issues

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

of 13,585

Rank

Percentile

Healthcare

Industry

of 590

Rank

Percentile

Medical Distribution

Subindustry

of 42

Rank

Percentile

To view Accendra Health’s complete esg history, request access »

Accendra Health Exits (1)

Accendra Health’s most recent exit was on 31-Aug-2012 from Movianto. The exit was categorized as .

Company Name Exit Date Exit Type Exit Size Status Buyers
Movianto 31-Aug-2012 Completed
To view Accendra Health’s complete exits history, request access »

Accendra Health Affiliates

Subsidiaries (7)

Name Industry Location Year Founded
Barista Acquisition I Mechanicsville, VA 2017
Owens & Minor International Logistics Mechanicsville, VA 2012
Owens & Minor Healthcare Supply Glen Allen, VA 2005
American Contract Systems Bloomington, MN 2000
Byram Healthcare White Plains, NY 1968
You’re viewing 5 of 7 affiliates. Get the full list.  »

Accendra Health FAQs

  • When was Accendra Health founded?

    Accendra Health was founded in 1881.

  • Where is Accendra Health headquartered?

    Accendra Health is headquartered in Glen Allen, VA.

  • What is the size of Accendra Health?

    Accendra Health has 6,500 total employees.

  • What industry is Accendra Health in?

    Accendra Health’s primary industry is Logistics.

  • Is Accendra Health a private or public company?

    Accendra Health is a Public company.

  • What is Accendra Health’s stock symbol?

    The ticker symbol for Accendra Health is ACH.

  • What is the current stock price of Accendra Health?

    As of 12-Nov-2026 the stock price of Accendra Health is $0.15.

  • What is the current market cap of Accendra Health?

    The current market capitalization of Accendra Health is $11.2M.

  • What is Accendra Health’s current revenue?

    The trailing twelve month revenue for Accendra Health is $2.55B.

  • Who are Accendra Health’s competitors?

    B. Braun, PRIMED Medical Products, Avanos Medical Deutschland, Mölnlycke Health Care, and O&m Halyard Apac are some of the 13 competitors of Accendra Health.

  • What is Accendra Health’s annual earnings per share (EPS)?

    Accendra Health’s EPS for 12 months was -$2.23.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process